News|Articles|June 20, 2013
High Potency APIs Video
A conversation with Kevin Brady of Alkermes about how high potency APIs are changing the way drugs are developed and manufactured in terms of process, equipment and regulations, including a case study that demonstrates the effective scale up or manufacture of a drug with a highly potent API.
Advertisement
A conversation with Kevin Brady of Alkermes about how high potency APIs are changing the way drugs are developed and manufactured in terms of process, equipment and regulations, including a case study that demonstrates the effective scale up or manufacture of a drug with a highly potent API.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Renewing Prosaic Generics for Cancer Treatment
2
Leveraging an Innovative Mid-Scale Manufacturing Solution to Meet Diverse Needs
3
Viral Safety 2.0: Plant-Ready Actions for ICH Q5A(R2) Compliance
4
Delaware Governor Meyer on Drug Pricing, Reshoring, and National Security
5